Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Inflamm Bowel Dis
; 28(11): 1725-1736, 2022 11 02.
Article
em En
| MEDLINE
| ID: mdl-35166347
This large retrospective study demonstrated the short- and long-term effectiveness and safety of ustekinumab in patients with Crohn's disease in real-world clinical practice, including those with refractory disease.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença de Crohn
/
Ustekinumab
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article